Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

July 30, 2007

Curt Furberg, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

Steven Nissen, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

Thomas Pickering, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

David Schade, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

Morris Schambelan, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

John Teerlink, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

Page updated: July 9, 2007